Connecting you to content on EBSCOhost

Works matching IS 17588340 AND DT 2012 AND VI 4 AND IP 3

Results: 5

1

Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 3, p. 95, doi. 10.1177/1758834012444499

By:

Aapro, Matti;
Cornes, Paul;
Sun, Diana;
Abraham, Ivo

Publication type:

Article

2

Improving survival and limiting toxicity: latest advances in treating human epidermal growth factor receptor 2 overexpressing breast cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 3, p. 139, doi. 10.1177/1758834012440834

By:

Abramson, Vandana G.;
Mayer, Ingrid A.

Publication type:

Article

3

Beta-adrenergic blocking drugs in breast cancer: a perspective review.

Published in:

Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 3, p. 113, doi. 10.1177/1758834012439738

By:

Barron, Thomas I.;
Sharp, Linda;
Visvanathan, Kala

Publication type:

Article

4

Poor-prognosis estrogen receptor- positive disease: present and future clinical solutions.

Published in:

Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 3, p. 127, doi. 10.1177/1758834012439338

By:

Lønning, Per E.

Publication type:

Article

5

Exemestane in the prevention setting.

Published in:

Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 3, p. 107, doi. 10.1177/1758834012438214

By:

Litton, Jennifer Keating;
Bevers, Therese B.;
Arun, Banu K.

Publication type:

Article